AHA 2018: DECLARE TIMI-58- Prof Stephen D. Wiviott

 

Prof Stephen D. Wiviott discusses the DECLARE TIMI-58 trial - The Dapagliflozin Effect on Cardiovascular Events.

 

Filmed by Radcliffe Cardiology on site at AHA 2018.

Video Category: 

  • Prevention & Risk Modification